2006
DOI: 10.1016/j.aca.2005.10.044
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of tegaserod in human plasma by high-performance liquid chromatography–tandem mass spectroscopy and its application to bioequivalence study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 2 publications
0
5
0
Order By: Relevance
“…Tg-NEs were found to be stable and homogenous under dilution and body temperature, with no appreciable changes over the time in terms of hydrodynamic diameter, PDI and drug payload for 24 h (Figure 5). These results predicted a good stability of the nanoemulsions in the bloodstream, especially since tegaserod has been shown to remain stable in these conditions [70]. The nanoemulsions integrity could be preserved to reach the BBB.…”
Section: Stability Study Of Tg-nes Over Timementioning
confidence: 62%
“…Tg-NEs were found to be stable and homogenous under dilution and body temperature, with no appreciable changes over the time in terms of hydrodynamic diameter, PDI and drug payload for 24 h (Figure 5). These results predicted a good stability of the nanoemulsions in the bloodstream, especially since tegaserod has been shown to remain stable in these conditions [70]. The nanoemulsions integrity could be preserved to reach the BBB.…”
Section: Stability Study Of Tg-nes Over Timementioning
confidence: 62%
“…The method is limited by time-consuming extraction procedure such as solid phase extraction (SPE) and the LLOQ of 0.20 ng/ml. In our study, because the clinical dosage of tegaserod is lower than Sonu [7], the LLOQ of 0.20 ng/ml is not sensitive enough. Present paper describes a simple, economic and yet sensitive LC-ESI-MS/MS method that can determine tegaserod plasma concentration in humans as low as 0.05 ng/ml using liquid-liquid extraction and can be used to evaluate the pharmacokinetics of tegaserod in humans.…”
Section: Introductionmentioning
confidence: 63%
“…Sonu Sundd Singh et al [7] described the pharmacokinetic parameters in 24 healthy volunteers receiving 6 mg of test and reference tegaserod formulations. The developed method in this paper was successfully used for a pharmacokinetic study in which plasma concentration of tegaserod in 36 healthy Chinese volunteers (Groups A-C) 0.0985 ± 0.0018 0.5085 ± 0.0145 0.5110 ± 0.0120…”
Section: Pharmacokinetic Studymentioning
confidence: 99%
See 1 more Smart Citation
“…The drug is not official in any Pharmacopoeia[ 2 – 4 ]. A thorough literature survey revealed a few HPLC-MS[ 5 6 ], HPLC[ 7 ] and spectrophotometric[ 8 9 ] methods for the analysis of TM in plasma and formulations. Voltametry offers a group of highly selective and sensitive methods.…”
mentioning
confidence: 99%